Callaghan John J, Liu Steve S
University of Iowa, Department of Orthopaedics and Rehabilitation, USA.
Iowa Orthop J. 2010;30:35-8.
Although the deferred and non-prosecution agreements entered into by five of the leading orthopaedic implant companies have caused our profession to re-examine the surgeon-industry partnerships that have helped advance the field, the legal and ethical considerations in that relationship have not changed. Moving forward, the surgeon must recognize that a truly valuable exchange must be demonstrated and delivered in that relationship for compensation to be warranted. This paper summarizes the value proposition in the orthopaedic surgeon-industry partnership.
尽管五家领先的骨科植入物公司达成的延期起诉协议和不起诉协议促使我们这个行业重新审视曾助力推动该领域发展的外科医生与产业界的合作关系,但这种关系中的法律和道德考量并未改变。展望未来,外科医生必须认识到,在这种关系中必须展现并实现真正有价值的交流,才有理由获得报酬。本文总结了骨科外科医生与产业界合作关系中的价值主张。